Ping’an Ding

1.6k total citations · 1 hit paper
68 papers, 999 citations indexed

About

Ping’an Ding is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, Ping’an Ding has authored 68 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 19 papers in Gastroenterology. Recurrent topics in Ping’an Ding's work include Gastric Cancer Management and Outcomes (36 papers), Metastasis and carcinoma case studies (20 papers) and Gastrointestinal Tumor Research and Treatment (18 papers). Ping’an Ding is often cited by papers focused on Gastric Cancer Management and Outcomes (36 papers), Metastasis and carcinoma case studies (20 papers) and Gastrointestinal Tumor Research and Treatment (18 papers). Ping’an Ding collaborates with scholars based in China, United States and United Kingdom. Ping’an Ding's co-authors include Lingjiao Meng, Meixiang Sang, Qun Zhao, Peigang Yang, Yuan Tian, Honghai Guo, Yishui Lian, Chenyu Sun, Lina Gu and Sihua Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Ping’an Ding

64 papers receiving 993 citations

Hit Papers

Mechanisms of immune checkpoint inhibitors: insights into... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping’an Ding China 16 436 367 286 285 172 68 999
Massimiliano Salati Italy 13 351 0.8× 313 0.9× 398 1.4× 212 0.7× 166 1.0× 58 945
Yukiko Niwa Japan 20 223 0.5× 134 0.4× 402 1.4× 380 1.3× 405 2.4× 41 913
Xiangqian Su China 18 380 0.9× 249 0.7× 395 1.4× 594 2.1× 324 1.9× 103 1.3k
Kojiro Eto Japan 17 229 0.5× 174 0.5× 396 1.4× 444 1.6× 437 2.5× 92 1.0k
Xiaosun Liu China 14 175 0.4× 116 0.3× 267 0.9× 207 0.7× 120 0.7× 25 647
Jian Suo China 18 201 0.5× 127 0.3× 357 1.2× 314 1.1× 459 2.7× 44 952
Sebastian Heikaus Germany 20 315 0.7× 88 0.2× 211 0.7× 223 0.8× 350 2.0× 51 1.0k
Mikito Mori Japan 18 453 1.0× 342 0.9× 206 0.7× 301 1.1× 314 1.8× 54 999
Seung‐Hoon Beom South Korea 17 150 0.3× 110 0.3× 459 1.6× 361 1.3× 230 1.3× 69 901
Ryu Shimada Japan 15 281 0.6× 289 0.8× 396 1.4× 141 0.5× 206 1.2× 48 811

Countries citing papers authored by Ping’an Ding

Since Specialization
Citations

This map shows the geographic impact of Ping’an Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping’an Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping’an Ding more than expected).

Fields of papers citing papers by Ping’an Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping’an Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping’an Ding. The network helps show where Ping’an Ding may publish in the future.

Co-authorship network of co-authors of Ping’an Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Ping’an Ding. A scholar is included among the top collaborators of Ping’an Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping’an Ding. Ping’an Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Ping’an, et al.. (2025). Aberrant CircTMEM45A Facilitates Inflammatory Progression of Esophageal Squamous Cell Carcinoma through m5C-Mediated NLRP3 Activation. Cancer Research. 85(14). 2694–2713. 3 indexed citations
2.
Ding, Ping’an, Jiaxiang Wu, Haotian Wu, et al.. (2025). Preoperative liquid biopsy transcriptomic panel for risk assessment of lymph node metastasis in T1 gastric cancer. Journal of Experimental & Clinical Cancer Research. 44(1). 43–43. 2 indexed citations
3.
Ding, Ping’an, Jiaxuan Yang, Jiaxiang Wu, et al.. (2025). Multimodal Artificial Intelligence‐Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology‐Positive Gastric Cancer. Advanced Science. 12(15). e2411490–e2411490.
4.
Zhang, Zhidong, et al.. (2025). A case report of giant retroperitoneal liposarcoma. Medicine. 104(12). e41923–e41923.
5.
Ding, Ping’an, Jiaxiang Wu, Honghai Guo, et al.. (2024). MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer. Molecular Carcinogenesis. 63(7). 1378–1391. 6 indexed citations
6.
7.
Zhang, Zhidong, et al.. (2024). A case report of retroperitoneal liposarcoma. Medicine. 103(37). e39633–e39633. 1 indexed citations
9.
Ding, Ping’an, et al.. (2024). CALD1 facilitates epithelial-mesenchymal transition progression in gastric cancer cells by modulating the PI3K-Akt pathway. World Journal of Gastrointestinal Oncology. 16(3). 1029–1045. 3 indexed citations
10.
Ding, Ping’an, Jiaxiang Wu, Renjun Gu, et al.. (2024). Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 181–181. 5 indexed citations
11.
Ding, Ping’an, Haotian Wu, Jiaxuan Yang, et al.. (2024). Myosteatosis predicts postoperative complications and long‐term survival in robotic gastrectomy for gastric cancer: A propensity score analysis. European Journal of Clinical Investigation. 54(8). e14201–e14201. 3 indexed citations
12.
Ding, Ping’an, Hao‐Tian Wu, Jiaxiang Wu, et al.. (2024). N6-methyladenosine modified circPAK2 promotes lymph node metastasis via targeting IGF2BPs/VEGFA signaling in gastric cancer. Oncogene. 43(34). 2548–2563. 19 indexed citations
13.
Ding, Ping’an, Haotian Wu, Peigang Yang, et al.. (2023). Sarcopenia: Molecular regulatory network for loss of muscle mass and function. Frontiers in Nutrition. 10. 1037200–1037200. 34 indexed citations
14.
Ding, Ping’an, Bibo Tan, Hongyan Wang, et al.. (2023). Screening of Differentially Expressed Genes Based on the ACRG Molecular Subtypes of Gastric Cancer and the Significance and Mechanism of AGTR1 Gene Expression. Journal of Personalized Medicine. 13(3). 560–560. 6 indexed citations
15.
Ding, Ping’an, Ziyi Li, Fei Liu, et al.. (2023). Circular RNA circ‐TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR‐452‐5p/DAG1 axis. Molecular Oncology. 17(7). 1437–1452. 11 indexed citations
16.
Ding, Ping’an, Haotian Wu, Chenyu Sun, et al.. (2023). Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib. BMC Gastroenterology. 23(1). 23–23. 7 indexed citations
17.
Ding, Ping’an, Pengpeng Liu, Lingjiao Meng, & Qun Zhao. (2023). Mechanisms and biomarkers of immune-related adverse events in gastric cancer. European journal of medical research. 28(1). 492–492. 13 indexed citations
18.
Ding, Ping’an, Peigang Yang, Li Yang, et al.. (2022). Impact of skeletal muscle loss during conversion therapy on clinical outcomes in lavage cytology positive patients with gastric cancer. Frontiers in Oncology. 12. 949511–949511. 9 indexed citations
19.
Ding, Ping’an, Honghai Guo, Peigang Yang, et al.. (2021). Association Between the Nutritional Risk and the Survival Rate in Newly Diagnosed GIST Patients. Frontiers in Nutrition. 8. 743475–743475. 13 indexed citations
20.
Sang, Meixiang, Lingjiao Meng, Sihua Liu, et al.. (2018). Circular RNA ciRS-7 Maintains Metastatic Phenotypes as a ceRNA of miR-1299 to Target MMPs. Molecular Cancer Research. 16(11). 1665–1675. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026